Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

People with alopecia areata often have lower iron levels than healthy people.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Atorvastatin in a keratin hydrogel may help treat skin scars effectively.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

SLE is likely one disease with various symptoms, not multiple distinct diseases.

Topical treatments led to hair regrowth in a man with linear morphea.

Children's Serum Sickness-Like Reaction is often linked to antibiotics, especially amoxicillin, and involves symptoms like rash, fever, and joint issues.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Female hair loss can be diagnosed using specific trichoscopy criteria.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Menopause-related skin changes may increase fungal infections and inflammation.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Genetic differences affect COVID-19 severity and treatment development.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.